NCT03487263 Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease Status COMPLETED Phase PHASE1
NCT03481348 Pharyngeal Electrical Stimulation in Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT03474263 IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS) Status WITHDRAWN Phase PHASE2
NCT03452618 Predictive Factors for the Diagnosis of Early Noninvasive Ventilation Equipment Status UNKNOWN Phase NA
NCT03427086 Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT03378375 Resting Energy Expenditure Equations in Amyotrophic Lateral Sclerosis, Creation of a ALS-specific Equation Status COMPLETED Phase N/A
NCT03377868 Optic Coherence Tomography in Patients With Amyotrophic Lateral Sclerosis Status UNKNOWN Phase NA
NCT03377309 Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients Status TERMINATED Phase PHASE2
NCT03367650 Epidemiology and Genetics of the Amyotrophic Lateral Sclerosis in the French West Indies Status UNKNOWN Phase NA
NCT03362658 Novel MRI Biomarkers for Monitoring Disease Progression in ALS Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03338114 Study to Evaluate the Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Upper or Lower Extremity Muscles Most Affected in Subjects With ALS Status WITHDRAWN Phase PHASE1/PHASE2
NCT03334786 Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS Status TERMINATED Phase PHASE1/PHASE2